News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Staff September 11, 2023 Iframe sync Post navigation Previous: New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext: XORTX Announces Participation at Upcoming Investor Conferences More Stories Healthcare News TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States Staff February 2, 2026 Healthcare News Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth Staff February 1, 2026 Healthcare News Patient Care AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai Staff February 1, 2026
